Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000875320-25-000179
Filing Date
2025-05-05
Accepted
2025-05-05 16:20:54
Documents
1
Period of Report
2025-05-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1746476447.html 4  
1 FORM 4 wk-form4_1746476447.xml 4 3723
  Complete submission text file 0000875320-25-000179.txt   5112
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Issuer) CIK: 0000875320 (see all company filings)

EIN.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 450 LEXINGTON AVE., 31ST FLOOR NEW YORK NY 10017
Business Address
Lagarde Michel (Reporting) CIK: 0001518973 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19319 | Film No.: 25913294